In short
Podcast Notes: Today, Explained - The End of Dieting
Episode Overview
- Title: The End of Dieting
- Host: Noel King
- Produced by: Miles Bryan
- Edited by: Jolie Myers
- Fact-Checked by: Laura Bullard
- Engineered by: Patrick Boyd, Andrea Kristinsdottir
- Description: An exploration of the implications of GLP-1 drugs on obesity treatment and the evolving narrative around dieting in America.
Key Themes and Discussions
Introduction of GLP-1 Drugs
- GLP-1 Drugs Overview:
- New class of medications reshaping obesity treatment.
- Made more affordable through recent policy changes by the Trump administration.
- Associated with declining obesity rates in the U.S.
Personal Narrative
Sumita Mukhopadhyay's Journey
- Background:
- Former executive editor of Teen Vogue.
- Experiences with weight gain linked to stress and family health issues.
- Health Concerns:
- Diagnosed as pre-diabetic with elevated cholesterol.
- Emotional struggles with body positivity and the decision to use medication.
Impact of Manjaro
- Initial Experience:
- Began using Manjaro, a GLP-1 drug, which reduces hunger and alters digestion.
- Faced side effects including nausea and digestive issues, but also experienced significant weight loss (50 pounds).
- Behavioral Changes:
- Medication led to improved eating habits, such as opting for healthier snacks and reducing compulsive eating.
Economic Considerations
- Cost Challenges:
- Initially affordable due to a coupon, the price escalated to $600-800 per month.
- Faced difficulties maintaining medication due to financial constraints.
Weight Regain and Emotional Rollercoaster
- Post-Medication Struggles:
- After stopping Manjaro, experienced regaining 60-70% of lost weight.
- Ongoing emotional impact and the challenge of facing one's body image and health.
Medical Expert Insights
- Dr. Dan Bessison's Perspective:
- Discusses historical context of obesity and medical approaches.
- Highlights the shift in treatment paradigms from lifestyle changes to medical interventions.
- Biological Understanding of Weight:
- Emphasis on the biological regulation of weight; weight loss is often met with biological resistance.
Cultural Narrative Shift
- New Weight Loss Approaches:
- Discussion on the changing landscape of obesity treatment, including medications that rival the effectiveness of bariatric surgery.
- Market Dynamics:
- Rising demand for medications and the potential neglect of comprehensive patient care.
Key Takeaways
- Obesity Treatment Evolution:
- The podcast emphasizes a transition from strict dieting and exercise to a more pharmacologically-driven approach to manage obesity.
- Complexity of Weight Management:
- The relationship between weight, health, and medication is nuanced, with psychological and social factors playing significant roles.
- Importance of Patient Education:
- Calls for better communication and education around new obesity treatments to prepare patients for long-term management.
Conclusion The episode concludes with an exploration of the future of dieting and obesity treatment, suggesting that the era of traditional dieting may be coming to an end as new medical options become available. The podcast raises critical questions about individual agency in weight management and the role of healthcare providers in guiding patients through these changes.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:03Today's episode of Today Explained is a rerun, but we have updated it with some news. Perhaps you saw President Trump recently announced a deal with two drug companies that's going to result in a drug drug drug. drugs. Perhaps you saw that he then revealed who in his administration is taking them. And we have Steve, we're Steve Seguir, head of public relations for the White House. He's taking it. Classic. Perhaps you saw someone then fainted in the Oval Office during that announcement. Classic. Here's the thing. These drugs appear to be working. Obesity rates in the U.S. are declining, but there are still unknowns.
0:41The relationship between diet, weight, and health seems like it should be clear by this point, but it's really not. Coming up on Today Explained, why the gospel on weight loss is always being rewritten, and how medications have added a brand new chapter.
1:06You're listening to Today Explained. Sumita Mukhopadai is a writer and editor who was very anxious when she was hired as the executive editor of Teen Vogue back in 2018. Like everyone else, Sumita had seen The Devil Wears Prada, and she knew that the fashion industry was unforgiving. But not long after she started there, she realized that things were changing. You know, I entered the fashion industry at a really unique moment where there was an increased interest in plus fashion. And so when I got the job at Teen Vogue, I started having all these fashion brands reaching out to me to be like, wow, we're so excited.
1:44We're launching a plus collection. We'd love to talk to you about it. We'd love to send it to you. How does it feel to be a fat fashion editor? And at the time, I had kind of newly gained the weight. And so I wasn't totally embracing it. I wasn't, I didn't, it didn't feel empowering. It was almost felt like something that was happening to me where I was like, oh, wait, I'm fat. Like, you know, I had to kind of get over that first step before being like, I'm fabulous. I love being fat. Okay, so you're in a period where Teen Vogue has become more accepting. It is okay to be a person in a larger body.
2:18And in fact, there's even some sort of advocacy or activism around the fact that there is more than one body type. And then you get some news that, again, changes how you see and experience all of this. What happened? While I was at Teen Vogue and kind of as I was leaving Teen Vogue, I had had a series of stressful family related things happen. My father passed away of diabetes related complications. My mother was diagnosed with breast cancer. I had this really hectic job and I was managing all of it. And my stress response was eating. and it was not just eating. It was like really not taking care of myself ultimately, right?
3:06It was taking Ubers. It was getting takeout. It was kind of not really having a lot of time for myself. And that did lead to some unwanted weight gain on my part. And I was having some mobility issues. I was having trouble kind of, I just thought it was because I was exhausted because I had never had these experiences, but I was having trouble getting up and down the stairs on the subway. and I would just chalk it up to like, oh, I'm just so busy, you know, like I have to take Ubers because I'm like busy and I'm exhausted. And I was having trouble keeping up on walks and I was having trouble sleeping.
3:39I wasn't feeling well. And, you know, on top of that, my clothes weren't fitting. And so I went to the doctor and, you know, this is after I had left Teen Vogue and like kind of after the pandemic, I decided to start the process of, you know, figuring out if I was okay and also, you know, what I could do because I knew and I understood that diets don't work, right? Like I knew I could restrict what I was eating, but eventually I'd gain the weight back and I really wanted something. I really wanted a strategy that would be more effective. And so I went in and got my blood work done and, you know, pretty much every indicator was elevated.
4:18So I was, had become pre-diabetic, my cholesterol was elevated. And so those scared me, right? Like I had just lost my father to exactly the things that I'm now looking at in my blood report. And so I was like, you know, I think it's finally time for me to really take this seriously and figure out, you know, a strategy to move forward. And she suggested Manjaro.
4:45It is a injectable that you take weekly. It slows your digestion, basically is how it works. and in doing so, it reduces the rate at which you can eat and how hungry you get. And so, you know, I decided to go on it.
5:03What did that mean for you? Like once you start taking it, what happens? Do you mean emotionally or physically? Both. Both. Entirely, I mean both. Thank you for asking. Yeah, yeah, for sure. I mean, emotionally, it was really hard to make the decision to go on it. I saw it as two things. I saw it as a betrayal to the kind of body positivity and feminism that I had ascribed to of loving yourself at any size and not trusting pharmaceutical interventions. And also there was another voice inside me that was like, this is how bad it's gotten, girl. Like you couldn't control this and now you have to take a drug.
5:37That's how not well you are. And so a lot of self-judgment, a lot of shame came out with the decision to go on the medication. Physically, it is a bumpy road. It was for me. For me, I struggled with very intense nausea. So one of the ways that it works is since it slows your digestion, if you overeat, you feel very sick. And then a lot of digestive issues. It is very hard to go to the bathroom when you're on it. You have to take all kinds of laxatives. They now have additional prescriptions they put people on that are taking it to help support with, you know, regular bowel movements. And so it was not the best physical experience.
6:22And then, you know, at a certain point I got used to it, but I think it was more that I just got used to managing the side effects. They never really went away for me. You have made, interestingly enough, being on Munjaro sound absolutely horrible, but I appreciate you being honest about the side effects because I don't hear talk about the side effects very often. What was the good in this? What kept you on it? It does something. And I think it's physiological and a doctor can speak more eloquently to this, but it does trigger something in your brain, a hormone that suggests that you're satiated.
7:00Right. And so it started to help me feel satisfied with less. One of my behaviors is I tend to compulsively eat in the evening, whether it's stress or just fun or boredom or binge watching TV, whatever it might be. I will sit down with like an array of snacks and kind of eat mindlessly, not always keeping track of how much I'm eating, not necessarily food that had good nutritional value. when I was on Manjaro I would finish dinner and I pretty much would not physically be hungry in the evening and I just wouldn't have space to eat anything else and if I got the munchies I started to reach for healthier snacks because I noticed that I digested them easier and so if I just ate an apple or some grapes I ate so many freaking grapes or a handful of carrots or whatever that might be and all the things we tell ourselves this is the healthy choice let's make the healthy choice The healthy choice all of a sudden became easier.
7:57And so that was part of why I stayed on it, that it really gave me this release from this yearning that I always had where it wasn't a challenging decision. I didn't feel a lot of strain around it, whereas historically when I would beat myself up for eating at night, I never felt like I could stop. And with the kind of pharmaceutical intervention, I was able to stop. Okay, so there are pros, there are cons. How is it going? I guess when Manjaro hit the market, they had given a manufacturer's coupon to early people, to people that had first started taking the drug. And, you know, I don't read the fine print, I don't know.
8:39No one does, girl. I thought that was my insurance covering it. I didn't understand that like the reason it costs that much was a coupon and not my insurance. And so the coupon is rescinded and overnight the drug becomes six to$800 a month. I think it was like, I think it was 800. And they were like, we can do this other coupon that will get you to like 600. Like I'm kind of like, these aren't the exact numbers, but all I'm saying is like, it was an insane amount of money that I was like, what? Like I live in New York city. You can't just take on another payment like that. That's crazy. Yeah, exactly.
9:16Exactly. I think the combination of the cost and the side effects, and I had lost a lot of weight. I think I lost 50 pounds about. Oh, wow. And I was feeling great. And I was like, let me just try without it. Let me phase out of it. And so I came off the drug at the end of 2023. And I will say maintained the loss for quite a bit of time. I probably gained like 10 to 15 pounds within like two or three months. And that was definitely not a great mental experience. Like I definitely came back to that feeling of control of like, oh my God, I'm losing control. I'm losing control. And, you know, but I was excited because I had made some lifestyle changes that I was maintaining and that felt like a really positive intervention.
10:05Now, this is like the first interview I'm doing about this in like six months. And so I will say the last six months have been really stressful for me. I launched a book. I got married. Thank you. Nothing like gaining weight for your wedding. But I started, you know, some of the things that I had been committing to like cooking and getting enough, you know, my steps every day and all of that like fell to the wayside a little bit. And so the weight started to creep on and creep on and creep on. And now I've probably gained back like 60 or 70 percent of what I lost, which has been really hard. You know, it's hard and it's also feels like it's forcing me to really face my relationship with my health and my own body.
10:52And to like, it's like I understand the options that are out there, but the options are limited. I wouldn't even say that I would necessarily go back on it because when I think about it, I just get sick to my stomach again. I'm just like, oh, I just don't know if I can go through that again. But, you know, it's been a roller coaster, emotional roller coaster, having the kind of high of like, oh, like the weight came off. And then to like be feel like I'm back to square one, even though I know in my mind and my heart and my spirit, I am not.
11:27Sumita Mukhopadhyay, writer and editor. Coming up, is the age of diet and exercise over?
11:45Support for Today Explained comes from Bombas. Perhaps you want to get in shape this year. Bombas wants to tell you about the all-new Bombas Sport Socks, engineered with sport-specific comfort for running, golf, hiking, skiing, snowboarding, and all sport. Meanwhile, for the loungers among us, Bombas has non-sport footwear available. But Bombas doesn't just offer sport and non-sport socks. They also offer super soft base layers that they claim will have you rethinking your whole wardrobe. Wardrobe, underwear, T-shirts, flexible, breathable, buttery, smooth, premium, everyday go-tos, they say, you won't want to leave the house without.
12:24Here's Nisha Chital. I've been wearing Bombas for several years now. I have several pairs. My whole family loves to wear Bombas. I have several pairs of Bombas ankle socks, and I have some no-show socks as well that are great for things like loafers and ballet flats. For every item you purchase, Bombas says an essential clothing item is donated to someone facing housing insecurity. One purchased, one donated, over 150 million donations and counting, I'm told. You can go to Bombas.com slash Explained and use code EXPLAINED for 20 % off your first purchase. That's B-O-M-B-A-S dot com slash Explained, code EXPLAINED at checkout.
13:08Support for the show comes from BoxyCat. There's a lot to love about having a cat in your home. But there's one thing that even the most ardent cat lover could do without. Stinky litter boxes. Boxy says that they can help. Boxy wants to be the last kitty litter you ever try. They say the difference is in their formula, which includes probiotics that can stop bacteria that cause odors. Plus, Boxy says their clumping power is superior, making it easier to scoop so your litter box can be less stinky without any of the fake fragrances. Here's our colleague, Andrew Melnizik, to tell us more. So my sister is that cat mom.
13:45She calls them her children. So when it comes to trying anything new for them, she's incredibly skeptic and always a little hesitant. That's why I was so excited to hear that she was really enjoying Boxy's cat litter. The first thing she noticed, there was just zero issues transitioning to cats. There was no drama from them, which, you know, cats can kind of push back and be a little bit drama. It was really a miracle. If you're tired of switching litters, looking for the one? Get Boxy at B-O-X-I-E-C-A-T dot com. It's the last letter you'll switch to. Enjoy 30 % off with code EXPLAINED at BoxyCat.com slash EXPLAINED.
14:26That's B-O-X-I-E-C-A-T dot com forward slash EXPLAINED.
14:36Support for today's show comes from Rubrik. Many companies are deploying AI agents at this time. They automate tasks, they handle workflows, they make decisions. And here is the thing. Sometimes, according to Rubric, they mess up. They might delete the wrong file. They might make changes you didn't authorize. They might go off script. When that happens, you can get stuck trying to figure out what went wrong and how to fix it. Enter Rubric Agent Cloud. Rubric Agent Cloud is a platform that they say lets you monitor, govern, and rewind AI agent actions. It's one platform. They say it helps you use more agents faster and without the risk.
15:18They say it runs in the background. They say it watches what's happening. They say it makes sure things stay on track. They say you can get full visibility. They say you can set guard rails so the agents don't go rogue. If your business relies on AI agents, you need the ability to monitor, govern, and rewind their actions, says Rubrik. Right now, our listeners get exclusive early access to Rubrik Agent Cloud. You can go to rubrik.com. That's R-U-B-R-I-K.com, rubrik.com.
15:57You're listening to Today Explained. I'm Dan Bessison. I'm an MD by training. I'm an endocrinologist. I'm here at the University of Colorado in Denver, and I do clinical work taking care of patients at our county hospital, Denver Health, and I do research here at the medical school. I'm also the director of this building called the Anschutz Health and Wellness Center. Dan, you have 47 jobs, man. All right, let's talk about the beginnings of this sort of cultural and medical interest in obesity. When did doctors start thinking of obesity as something that needed to be fixed, something that needed medical attention?
16:41I think there's always been people with really high weights that doctors thought, well, that's probably a health problem. But I don't think it entered the general public consciousness until sort of the late 80s to the mid 90s. The disease is obesity. But obesity is just a symptom of the real problem we as a nation face. Frances, you've been overweight since you can remember? Since a child. About early teens. Americans overeat. We are obsessed with food. And it's an obsession that's killing us. And when Greta was one year old, she weighed 100 pounds. Almost 100. Almost 100. That's a lot. I think people looked around and thought, what's going on here?
17:27There seems to be more and more people at higher weights. And NIH had an expert panel that defined obesity using BMI. BMI is sort of controversial, but that was the point at which we had this accepted standard. And shortly after that, the CDC looked at data they had and said, what's been happening with obesity? And I think they were sort of shocked to find there was just a dramatic increase in the number of people with obesity. And so in 1999, they published these maps, these CDC obesity maps. Maybe some people have seen those. And they really brought a lot of attention to what really looked like an epidemic.
18:09If you had looked at those numbers and it was HIV or cancer, people would be quite worried. And people said, gosh, something is happening here. We should do something about this.
18:22And what was the something that doctors decided they should do? Yeah, I think that the NIH panel had thought about levels of weight and that treatment or what intervention somebody did should be based on how serious the problem was. So people with a modest increase in their weight might change their diet and increase their physical activity. People with a more severe weight problem might take a medication. And those at the highest weight might benefit from surgery. For most Americans, lifestyle is what was suggested. And I think at that point, we were still early in understanding the biologic basis of weight regulation.
19:03And we all eat, we all move, and it seems like we choose those things. And so the obvious first step was to say, maybe people just don't know what to eat. And if they just thought about it some more and ate less and moved more, that this problem might go away. So that was the first thought. And the Surgeon General had a call to action. Obesity, a major problem that has increased dramatically since 1990. Based on these numbers rising of obesity, saying, you know, people ought to move more and eat a healthier diet. When it comes to physical inactivity, obesity, diabetes, the fact of the matter is we're moving in the wrong direction in terms of these areas.
19:44The advice seems obvious. Change what you eat and move more. Do diet and exercise prove to work? I think there's a couple of ways to look at that. One is around this same time, there was a study published, the Diabetes Prevention Program. And what they found was that a modest weight loss, a 5 % weight loss, could reduce the risk of developing type 2 diabetes by half. It was a really dramatic study. And so it was really based on that that people said, gosh, this is achievable and it has clear health benefits of 5 % weight loss. I'm just doing the math in my head. If you weigh 200 pounds, that's take 10 pounds off.
20:33Yeah. 300 pounds, take 15 pounds off. That feels like nothing. It seems like a small change in weight and yet it had dramatic benefits. I got to tell you, I mean, I see people in clinic, and so I've spent, whatever, 20 years trying to sell the benefits of a 5 % weight loss. Most people don't buy it. Most people want more weight loss than that. It's not a weight loss that most people see in the mirror or that their friends are going to notice, but it has clear health benefits and has become a benchmark of what a clinically significant weight loss is. A little bit of weight loss helps. So what happened after the study was over with these folks who lost 5 % of their weight and then saw their health improve?
21:13Did they keep the weight off? Most lifestyle studies show that most people regain much of the weight. It's not like everybody regains all of the weight, but much of the weight is regained. What has happened over the last 25 years is a real explosion in our understanding of the biology that underlies weight regulation. I think now we think of weight much like we think about blood pressure or glucose, that there's complex biology that the body's got its own idea about what it wants to weigh. And what it seems like the body wants to do, it doesn't regulate around a set point. It regulates around a trajectory of gradual weight gain across the life.
21:55So the biology of weight really pushes back against efforts to change our diet. And so that's why people regain the weight is when they lose weight, the body goes, this is not good. And the people become more hungry. Their energy expenditure goes down. And these things tend to push the weight back up to where it was before. Were there, you mentioned two other ways that doctors saw of treating obesity, medications and surgeries. How common was it for a doctor to say, you, sir or madam, you're going to need medication, you're going to need surgery? I don't remember so much of that like 20 years ago.
22:32Only maybe one or two percent of people ever had that conversation, ever got that medication. And there are a number of reasons for that. One is the older medicines had some side effects. There were some bad stories about health problems with Fen-Fen and other medicines. Oh, Fen-Fen. If you took the diet drug combination known as Fen-Fen or the diet drugs Pondamin or Redux, you may have heart valve problems and not know it. Before Chicago area women are taking the makers of Fen-Fen to court. It's been one week since the prescription diet drug was pulled off the market. And I think, too, doctors and patients, doctors especially have this idea that, well, Mrs.
23:11Jones, you ought to be able to handle this on your own. This idea that weight is regulated, it's taken a long time to get any traction there. Doctors would say things like, you know, if you show me you can stick to a diet, well, then I'll maybe talk to you about a medicine. We don't do that with diabetes or high blood pressure. We're very quick to go to a medication in those conditions. So I think there's a lot of maybe bias and stigma directed at people living with obesity that we tend to blame them for their health problem. So medicines that weren't super effective and an environment that really thought that people could do this on their own.
23:46How long have you been in this line of work, Dr. Dan? I'm an old person with kind of gray hair. I prescribe Fen-Phen, so I've been doing this for, gosh, whatever, almost 30 years. You've been doing this for 30 years. Sometime in the last 24 months, I became aware of Ozempic. A lot of people became aware of Ozempic. I'm just wondering what the conversation was like in the medical community among doctors who do your type of work about the fact that there are these GLP-1 drugs that seem to work magically, work for a lot of people, and are now widely available. Yeah, I would use the term game changer.
24:27There's never been anything like this.
Read the full transcript
24:32we've done studies with older medications and you know the medications worked okay but people weren't happy with them these medicines just uh not only the ones we have now which are semaglutide and trisepatide but the ones that are coming after that that are in clinical trials we're in a time now that medications are likely to provide the kind of weight loss that we used to only see with bariatric surgery. I understand that there's more than 100 medications in this anti-obesity medication pipeline. We've been doing studies with some of the next generation, and they're even more effective than the semaglutide and trisepatide are.
25:11Oh, damn. Yeah. And, you know, when we have somebody go to bariatric surgery, we prepare them for that. They see a psychologist. They see a nutritionist. They talk to other people who've had surgery and say, how was that for you? They think about it. And then it's kind of a go, no go. Either you have surgery or you don't, and you get what you get. Medications are going to give that kind of weight loss, but we're not preparing people for that. What does your life look like when you're not interested in food? I had a woman tell me, my husband took me out to this fancy restaurant here in Denver for my birthday.
25:43He was so excited. I looked at the food and I thought, gee, this is not going to work for me. So it makes changes in people's relationships with other folks. When people see someone losing weight, they wonder, what are you doing? Do you have cancer? Who do you tell that you're out of medicine? What do you tell them about why and what your goals are? What are your goals? How much weight do you want to lose? And how will you know when you're done? These are questions that we've never had to ask before. And we don't have good data. And people are willing to pay. So there's all these market forces with people just want a medicine.
26:15They don't want a doctor. They don't want advice. They just want the medicine. But they don't really know what they're getting into. So So it's a bit of a chaotic environment. I think the key message I'd ask people to understand is this idea that weight is biologically regulated and that it has some health problems for some people, maybe even many people, and that ideally they find somebody that they can talk to, a doctor or a health care provider, that they can get useful information from over time because it's a journey.
26:54Dr. Dan Bessison, he's an endocrinologist. Miles Bryan produced today's show. It was a rerun. Jolie Myers edited. Laura Bullard fact-checked. Andrea Kristen's daughter and Patrick Boyd are our engineers. I'm Noelle King. It's Today Explained.
27:21Thank you.
From the publisher
The Trump administration is making GLP-1s more affordable. This class of drugs seems to have forever changed the game on diet and exercise for Americans.
This episode was produced by Miles Bryan, edited by Jolie Myers, fact-checked by Laura Bullard, engineered by Patrick Boyd and Andrea Kristinsdottir, and hosted by Noel King.
A pharmacist holds a box of Ozempic brand semaglutide medication. Photo by George Frey/Bloomberg via Getty Images.
Listen to Today, Explained ad-free by becoming a Vox Member: vox.com/members. New Vox members get $20 off their membership right now. Transcript at vox.com/today-explained-podcast.
Learn more about your ad choices. Visit podcastchoices.com/adchoices




